Indaptus Therapeutics is trading 12.57% up now at $2.88 after announcing a roughly $24 million private placement on September 10, 2026.

  • The financing covers 20,338,974 shares, with proceeds intended for working capital, research and development, and general corporate purposes.
  • Shares rose from $1.13 on September 1 to $2.56 on September 10.
  • The broader market is higher on September 11, while trading activity is elevated amid the multi-session advance.